{ "ok": true, "listing": { "id": "lst_01M2ZD0N4REKWT1D4T7F2V1YFB", "slug": "home-vhio", "businessName": "Home - VHIO", "legalName": "", "description": { "short": "The Vall d’Hebron Institute of Oncology (VHIO) is a reference center for personalized medicine in oncology created in 2006. Thanks to its pioneering model of multidisciplinary and translational research and its participation in consortia and projects with other prestigious centers around the world, it has positioned itself as one of the most important comprehensive centers in Europe capable of transforming, in record time, the latest research discoveries in the laboratory in early clinical trials and, therefore, in new opportunities for patients.", "full": "The Vall d’Hebron Institute of Oncology (VHIO) is a reference center for personalized medicine in oncology created in 2006. Thanks to its pioneering model of multidisciplinary and translational research and its participation in consortia and projects with other prestigious centers around the world, it has positioned itself as one of the most important comprehensive centers in Europe capable of transforming, in record time, the latest research discoveries in the laboratory in early clinical trials and, therefore, in new opportunities for patients." }, "industry": "VHIO", "website": "https://vhio.net/", "rootDomain": "vhio.net", "listingOrigin": "discovered", "entityType": "business", "entitySubtype": "commercial_organization", "entityClassification": { "type": "business", "subtype": "commercial_organization", "confidenceScore": 73, "classifiedAt": "2026-09-20T12:35:18.594Z", "government": null }, "placementType": "global", "location": { "placementType": "global", "countryCode": "", "countryName": "Global", "flag": "", "region": "", "city": "", "mode": "online" }, "primaryCategory": null, "claimStatus": "unclaimed", "verificationStatus": "unverified", "verified": false, "businessVerification": { "applicable": true, "status": "pending", "level": "none", "label": "Not Registry Verified", "badgeColor": "neutral", "countsAsVerified": false, "authority": null, "registryId": null, "matchScore": 0, "authorityCode": null, "lei": null, "jurisdiction": null, "registeredLegalName": null, "registryStatus": null, "registryUrl": null, "checkedAt": null, "verifiedAt": null, "nextCheckAt": null }, "businessVerified": false, "commercialStatus": "free", "agentStatus": "active", "paidProfile": false, "freshnessStatus": "current", "media": { "logo": "https://vhio.net/favicon.ico", "explicitLogo": null, "favicon": null, "fallback": "https://vhio.net/favicon.ico" }, "scores": { "dataConfidence": 80, "quality": 80, "verification": 0 }, "qualityScore": 80, "urls": { "directory": "https://directory.websdocs.com/business/home-vhio", "json": "https://directory.websdocs.com/business/home-vhio.json", "website": "https://vhio.net/", "gateway": null }, "publishedAt": "2026-09-20T12:35:19.498Z", "updatedAt": "2026-09-20T12:35:30.937Z", "organizationType": "organization", "language": { "primary": "en-GB", "supported": [ "en-GB" ], "currencies": [] }, "categories": [ { "slug": "other-businesses", "name": "Other Businesses & Services", "primary": true, "confidenceScore": 35 } ], "services": [], "products": [], "agentCapabilities": [ { "key": "booking", "name": "Online booking", "description": "Detected from public website navigation or discovery metadata.", "protocol": "http", "actionUrl": "https://www.facebook.com/vhiobarcelona", "method": "GET", "authenticationRequired": false }, { "key": "support", "name": "Online support", "description": "Detected from public website navigation or discovery metadata.", "protocol": "http", "actionUrl": "https://vhio.net/management-and-support-areas/", "method": "GET", "authenticationRequired": false } ], "contacts": [ { "type": "email", "label": "Public email", "value": "info@vhio.net", "url": "https://mailto:info@vhio.net/", "platform": "email", "primary": true, "verificationStatus": "public_source" }, { "type": "phone", "label": "Public phone", "value": "115-117 08035", "url": null, "platform": "phone", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "es", "value": "https://es.linkedin.com/company/vall-d%27hebron-institut-d%27oncologia", "url": "https://es.linkedin.com/company/vall-d%27hebron-institut-d%27oncologia", "platform": "es", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "facebook", "value": "https://www.facebook.com/vhiobarcelona", "url": "https://www.facebook.com/vhiobarcelona", "platform": "facebook", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "facebook", "value": "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fvhio.net%2F2026%2F09%2F14%2Fvhiodivulga-a-new-way-of-connecting-science-and-society%2F", "url": "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fvhio.net%2F2026%2F09%2F14%2Fvhiodivulga-a-new-way-of-connecting-science-and-society%2F", "platform": "facebook", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "facebook", "value": "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fvhio.net%2F2026%2F09%2F14%2Fapplications-open-for-vhio4stem-2027-the-mentoring-programme-for-4th-eso-students%2F", "url": "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fvhio.net%2F2026%2F09%2F14%2Fapplications-open-for-vhio4stem-2027-the-mentoring-programme-for-4th-eso-students%2F", "platform": "facebook", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "facebook", "value": "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fvhio.net%2F2026%2F09%2F10%2Ffinal-overall-survival-results-of-the-phase-3-matterhorn-study-support-perioperative-immunotherapy-as-a-new-standard-treatment-option-for-resectable-localized-gastric-or-gastroesophageal-junction-can%2F", "url": "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fvhio.net%2F2026%2F09%2F10%2Ffinal-overall-survival-results-of-the-phase-3-matterhorn-study-support-perioperative-immunotherapy-as-a-new-standard-treatment-option-for-resectable-localized-gastric-or-gastroesophageal-junction-can%2F", "platform": "facebook", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "facebook", "value": "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fvhio.net%2F2026%2F09%2F09%2Frna-analysis-improves-classification-of-brca1-variants-enabling-more-accurate-cancer-risk-assessment%2F", "url": "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fvhio.net%2F2026%2F09%2F09%2Frna-analysis-improves-classification-of-brca1-variants-enabling-more-accurate-cancer-risk-assessment%2F", "platform": "facebook", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "facebook", "value": "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fvhio.net%2F2026%2F09%2F03%2Ftwo-vhio-researchers-recognised-in-the-inaugural-esmo-leadership-and-career-development-awards%2F", "url": "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fvhio.net%2F2026%2F09%2F03%2Ftwo-vhio-researchers-recognised-in-the-inaugural-esmo-leadership-and-career-development-awards%2F", "platform": "facebook", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "facebook", "value": "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fvhio.net%2F2026%2F08%2F20%2Fnovel-treatment-combination-improves-disease-control-previously-treated-advanced-renal-cancer-compared-standard-care%2F", "url": "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fvhio.net%2F2026%2F08%2F20%2Fnovel-treatment-combination-improves-disease-control-previously-treated-advanced-renal-cancer-compared-standard-care%2F", "platform": "facebook", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "facebook", "value": "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fvhio.net%2F2026%2F08%2F03%2Fintratumoral-fusobacterium-as-a-prognostic-and-predictive-biomarker-in-resectable-colorectal-cancer%2F", "url": "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fvhio.net%2F2026%2F08%2F03%2Fintratumoral-fusobacterium-as-a-prognostic-and-predictive-biomarker-in-resectable-colorectal-cancer%2F", "platform": "facebook", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "instagram", "value": "https://www.instagram.com/vhiobarcelona/", "url": "https://www.instagram.com/vhiobarcelona/", "platform": "instagram", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "linkedin", "value": "https://www.linkedin.com/shareArticle?mini=true&", "url": "https://www.linkedin.com/shareArticle?mini=true&", "platform": "linkedin", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "twitter", "value": "https://twitter.com/VHIO", "url": "https://twitter.com/VHIO", "platform": "twitter", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "twitter", "value": "https://twitter.com/intent/tweet?text=VHIODivulga%3A+a+new+way+of+connecting+science+and+society&", "url": "https://twitter.com/intent/tweet?text=VHIODivulga%3A+a+new+way+of+connecting+science+and+society&", "platform": "twitter", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "twitter", "value": "https://twitter.com/intent/tweet?text=Applications+open+for+VHIO4STEM+2027%2C+the+mentoring+programme+for+4th+ESO+students&", "url": "https://twitter.com/intent/tweet?text=Applications+open+for+VHIO4STEM+2027%2C+the+mentoring+programme+for+4th+ESO+students&", "platform": "twitter", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "twitter", "value": "https://twitter.com/intent/tweet?text=Final+overall+survival+results+of+the+phase+3+MATTERHORN+study+support+perioperative+immunotherapy+as+a+new+standard+treatment+option+for+resectable%2C+localized+gastric+or+gastroesophageal+junction+cancer&", "url": "https://twitter.com/intent/tweet?text=Final+overall+survival+results+of+the+phase+3+MATTERHORN+study+support+perioperative+immunotherapy+as+a+new+standard+treatment+option+for+resectable%2C+localized+gastric+or+gastroesophageal+junction+cancer&", "platform": "twitter", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "twitter", "value": "https://twitter.com/intent/tweet?text=RNA+analysis+improves+classification+of+BRCA1+variants%2C+enabling+more+accurate+cancer+risk+assessment&", "url": "https://twitter.com/intent/tweet?text=RNA+analysis+improves+classification+of+BRCA1+variants%2C+enabling+more+accurate+cancer+risk+assessment&", "platform": "twitter", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "twitter", "value": "https://twitter.com/intent/tweet?text=Two+VHIO+researchers+recognised+in+the+inaugural+ESMO+Leadership+and+Career+Development+Awards&", "url": "https://twitter.com/intent/tweet?text=Two+VHIO+researchers+recognised+in+the+inaugural+ESMO+Leadership+and+Career+Development+Awards&", "platform": "twitter", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "twitter", "value": "https://twitter.com/intent/tweet?text=Novel+treatment+combination+improves+disease+control+in+previously+treated+advanced+renal+cancer+compared+to+standard+of+care&", "url": "https://twitter.com/intent/tweet?text=Novel+treatment+combination+improves+disease+control+in+previously+treated+advanced+renal+cancer+compared+to+standard+of+care&", "platform": "twitter", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "twitter", "value": "https://twitter.com/intent/tweet?text=Intratumoral+Fusobacterium+as+a+prognostic+and+predictive+biomarker+in+resectable+colorectal+cancer&", "url": "https://twitter.com/intent/tweet?text=Intratumoral+Fusobacterium+as+a+prognostic+and+predictive+biomarker+in+resectable+colorectal+cancer&", "platform": "twitter", "primary": false, "verificationStatus": "public_source" }, { "type": "social", "label": "youtube", "value": "https://www.youtube.com/channel/UCgk0_kjNS4NgJ6910KNrnYg", "url": "https://www.youtube.com/channel/UCgk0_kjNS4NgJ6910KNrnYg", "platform": "youtube", "primary": false, "verificationStatus": "public_source" } ], "serviceAreas": [], "sources": [ { "type": "website", "url": "https://vhio.net/", "title": "Home - VHIO", "primary": true, "lastObservedAt": "2026-09-20T12:35:02.159Z" }, { "type": "website", "url": "https://vhio.net/events/", "title": "Events - VHIO", "primary": false, "lastObservedAt": "2026-09-20T12:35:02.159Z" }, { "type": "website", "url": "https://vhio.net/hrs4r/", "title": "HRS4R - VHIO", "primary": false, "lastObservedAt": "2026-09-20T12:35:02.159Z" }, { "type": "website", "url": "https://vhio.net/news/", "title": "News - VHIO", "primary": false, "lastObservedAt": "2026-09-20T12:35:02.159Z" }, { "type": "website", "url": "https://vhio.net/laboratory-animal-service-las/", "title": "Laboratory Animal Service (LAS) - VHIO", "primary": false, "lastObservedAt": "2026-09-20T12:35:02.159Z" }, { "type": "website", "url": "https://vhio.net/about-cancer/", "title": "About Cancer - VHIO", "primary": false, "lastObservedAt": "2026-09-20T12:35:02.159Z" }, { "type": "website", "url": "https://vhio.net/contact/", "title": "Contact - VHIO", "primary": false, "lastObservedAt": "2026-09-20T12:35:02.159Z" }, { "type": "website", "url": "https://vhio.net/transversal-services/", "title": "Transversal services - VHIO", "primary": false, "lastObservedAt": "2026-09-20T12:35:02.159Z" } ], "timestamps": { "firstDiscoveredAt": "2026-09-20T12:35:02.159Z", "lastCrawledAt": "2026-09-20T12:35:19.498Z", "lastVerifiedAt": null, "publishedAt": "2026-09-20T12:35:19.498Z", "updatedAt": "2026-09-20T12:35:30.937Z" }, "gatewayDiscovery": { "status": "unmapped", "activeAgent": false, "urls": {}, "capabilities": { "ask": false, "checkout": false }, "checkedAt": null }, "quoteRequest": { "available": false, "endpoint": null } }, "canonicalUrl": "https://directory.websdocs.com/business/home-vhio", "generatedAt": "2026-09-22T01:33:59.100Z" }